Characterization of the natural methylation pattern of p16 CpG islands in human tissue samples of various pathological states may elucidate the mechanisms accounting for the diverse stability of p16 methylation and could potentially be used to develop a tumor-specific methylation biomarker assay. This evidence concerns the gene CDKN2A and neoplasm.